Karo Pharma AB Stock
Price
Target price
-
-
-
-
-
?49.08
WKN: A14YW4 / Symbol: KARO / Name: Karo Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Karo Pharma AB Stock
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Karo Pharma AB.
With a target price of 49 € there is potential for a 800.74% increase which would mean more than doubling the current price of 5.44 € for Karo Pharma AB.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Medivir AB | 1.710% | 5.694% | 3.304% | -30.035% | 249.412% | -79.535% | -85.187% |
| NanoViricides Inc. | 0.000% | 6.522% | 28.947% | 19.512% | 58.065% | 12.214% | -56.041% |
| Actinium Pharmaceuticals Inc. | 1.520% | -8.005% | -8.641% | -39.280% | -34.300% | -87.609% | -86.328% |
Comments
Karooooo (KARO) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its "buy" rating reaffirmed by Needham & Company LLC.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its price target lowered by UBS Group AG from $60.00 to $55.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KARO provided by MarketBeat